BNET Industries
Last Fiscal Year Sales:$102.5M
- Public
- IN
Dow Jones Description
In just over a decade, Strides Arcolab has grown phenomenally to become one of India's largest exporters of pharmaceutical formulations. As a group, our annual sales approach $100 million in 2003 - 2004. Strategically, we have re-oriented our positioning to capture a greater share of the regulated markets. The group ethos is based on "leadership through partnering". Our foray into the regulated markets is in partnership with pharma majors. We have also launched global initiatives to promote products for HIV/AIDS, tuberculosis and malaria. Our R&D department is being expanded to further enhance quality driven processes and drug development capabilities. We manufacture a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Our range of dosage forms is equally impressive soft gel capsule, hard gel capsules, tablets and dry and wet injectables. Last but not least are our awards and accreditations MHRA, MCC, and TGA. Our top management has more than a hundred years of collective experience in the pharmaceutical industry.
CEO, North America Operations
Adam LevittNumber of Employees 1,251
Peer Companies
NAICS Code Pharmacies and Drug Stores: 446110
Recent Events
-
Strides Arcolab launches anti-swine flu drug
-
Glance-European Factors - Shares seen opening higher
News & Analysis
Filter by
strides arcolab ltd. - All News and Analysis
Akorn-Strides, LLC Announces FDA Approval for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL
LAKE FOREST, Ill. -- Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approval for an Abbreviated New Drug Application ANDA for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL in 10 mL vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2004 by...
Akorn-Strides, LLC Announces FDA Approvals for Dexamethasone Sodium Phosphate Injection USP, 4 mg /mL and Dexamethasone Sodium Phosphate Injection USP, 10 mg /mL
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approval of two ANDAs for Dexamethasone Sodium Phosphate Injection USP, 4 mg base/mL in 1mL, 5 mL, and 30 mL vials, and Dexamethasone Sodium Phosphate Injection USP, 10 mg base/mL in 10 mL vials. Akorn-Strides, LLC is a Joint Venture that...
Akorn-Strides, LLC Announces the First Commercial Product Launch for the Joint Venture, Rifampin for Injection
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the first commercial product launch for the Joint Venture, Rifampin for Injection USP, 600 mg/vial. Rifampin is used in the treatment of all forms of tuberculosis in conjunction with Isoniazid and Ethambutol. To date, the company has filed for 18 ANDAs...
Akorn-Strides, LLC Announces FDA Approvals for Famotidine Injection USP, 20 mg/2mL Single-Dose Vials and Famotidine Injection USP, 40 mg/4mL & 200 mg/20 mL Multiple-Dose Vials
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approvals of two ANDAs for Famotidine Injection USP, 20 mg/2mL Single-Dose Vials and 40 mg/4mL & 200 mg/20mL Multiple-Dose Vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE:...
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approval of an ANDA for Rifampin for Injection USP, 600 mg/vial. This is the first lyophilized Injectable product approval for the Joint Venture. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and...
Akorn-Strides, LLC Announces FDA Approval for Flumazenil Injection USP, 0.1 mg/mL - 5mL and 10 mL Multiple Dose Vials
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approval of an ANDA for Flumazenil Injection USP, 0.1 mg/mL, packaged in 5 mL and 10 mL Multiple Dose Vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ:AKRX) and Strides Arcolab Limited (NSE:STAR) (BSE:532531)....
Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approvals of two ANDAs for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab...
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approval of an ANDA for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL equivalent to Phenytoin Sodium. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ:AKRX) and Strides Arcolab Limited (NSE:STAR) (BSE:532531). The primary...
Akorn-Strides, LLC Announces FDA Approval for Tobramycin Injection USP, 80 mg/2mL and 1.2 grams/30mL
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced the approval of an ANDA for Tobramycin Injection USP, 80 mg/2mL and 1.2 grams/30mL. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR, BSE: 532531). The primary mission for...
Akorn-Strides, LLC Announces its First ANDA Approval For Keterolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL
BUFFALO GROVE, Ill. -- Akorn-Strides, LLC today announced its first ANDA approval for Keterolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR)(BSE: 532531). The primary mission for the...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Adam Levitt | CEO, North America Operations |
| Mark Bisset | CEO & Reg Director, Asia |
| Rudi Jansen | CEO Europe |
| S. A. Manikandan | CEO, Brands |
| V. S. Iyer | CEO, India Operations |
| Mohan Ram Prasad | President, Technical Services Latin American Operations |
| Nitin Ghadiyar | President Strategic Initiatives |
| Ravi Seth | CEO, International Operations |
| Suresh Venkatram | Chief Scientific Officer |
| T. S. Rangan | Group CFO |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Mr Arun Kumar | Vice Chairman & Managing Director or |
| Deepak Vaidya | Chairman & Member (Ned) |
| A. K. Nair | Board of Directors |
| D. G. Prasad | Board of Directors |
| Elcemar Almeida | Board of Directors |
| Elcemer Almeida | Board of Directors |
| K. R. Ravishankar | Board of Directors |
| M. R. Umarji | Board of Directors |
| P. M. Thampi | Board of Directors |
| Ronald Ling | Board of Directors |
| Virtanes Saatci | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO, North America Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO & Reg Director, Asia | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO Europe | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO, Brands | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO, India Operations | Current |
| Strides Arcolab Limited | President, Technology Services | Former |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | President, Technical Services Latin American Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | President Strategic Initiatives | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | CEO, International Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Group CFO | Current |
Founder and Promoter Director of Strides, he is on the Board as Managing Director since inception i.e.June 1990. Possesses rich and value added experience in the pharmaceutical industry, Mr.Arun Kumar 's earlier stints include being the General Manager of British Pharmaceuticals Laboratories Ltd.
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Vice Chairman & Managing Director or | Current |
| Strides Arcolab Limited | Board of Directors | Current |
Appointed to the Board in January, 1998 and Chairman of the Board in December, 2005 .Mr.Vaidya is country head of Symphony Capital Partners (Asia)Pte.,Ltd., (previously known as M/s.Schroder Ventures Group), Mumbai, India and has got valuable corporate experience in the financial field in India and abroad.
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Chairman & Member (Ned) | Current |
| Strides Arcolab Limited | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
A first generation entrepreneur, Mr. Almeida brings nearly two decades of experience in the Pharma Industry. Based at Rio De Janeiro, Brazil, he has been associated with Strides when Strides acquired Infabra and set up Cellofarm in Brazil. He is a key contributor to the development of business strategy for Latin American Markets and plays a significant strategic and leadership role.
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Symphony Capital Partners Limited | Principal | Current |
| Strides Arcolab Limited | Board of Directors | Current |
| Parkway Holdings Limited | General Manager | Former |
| McKinsey & Company, Inc. | Management Consultant | Former |
| INSEAD | MBA | Former |
| University of Oxford | MA | Former |
| University of London | Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Strides Arcolab Limited | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Systemax Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about SYX
-
Weight Watchers International, Inc. Q3 2009 (Qtr End 10/03/09) Earnings Call Transcript
on Nov 10, 2009about WTW
-
AC Moore Arts & Crafts Inc. Q3 2009 Earnings Conference Call
on Nov 06, 2009about ACMR
-
Omnicare, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about OCR
-
MarineMax Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 05, 2009about HZO



